Targeting the Gut–Brain Axis with Plant-Derived Essential Oils: Phytocannabinoids and Beyond
Nutrients · 03.05.2025 · 17 (9) · 1578
DOI: 10.3390/nu17091578 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.05.2025. Verfasst von Luca Camarda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Biotechnology (FaBiT), Food Chemistry and Nutraceutical Lab, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, …. Hauptthemen laut MEDLINE: Oils, Volatile, Gastrointestinal Microbiome, Brain, Cannabinoids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The gut–brain axis (GBA) is a complex bidirectional communication system that links the gastrointestinal tract and the central nervous system. Essential oils (EOs) have emerged as promising natural compounds capable of modulating this axis.
Methods
A comprehensive analysis of the recent literature was conducted, focusing on studies investigating the effects of EOs on the GBA. Particular attention was given to the endocannabinoid system, the role of cannabis-derived EOs, and other plant-based EOs with potential neuroprotective and gut microbiota-modulating effects.
Results
Among the EOs analyzed, cannabis essential oil (CEO) gained attention for its interaction with cannabinoid receptors (CBR1 and CBR2), modulating gut motility, immune responses, and neurotransmission. While acute administration of the CEO reduces inflammation and gut permeability, chronic use has been associated with alterations in gut microbiota composition, potentially impairing cognitive function. Other EOs, such as those from rosemary, lavender, eucalyptus, and oregano, demonstrated effects on neurotransmitter modulation, gut microbiota balance, and neuroinflammation, supporting their potential therapeutic applications in GBA-related disorders.
Conclusions
EOs demonstrate promising potential in modulating the GBA through mechanisms including neurotransmitter regulation, gut microbiota modulation, and anti-inflammatory activity. At the same time, phytocannabinoids offer therapeutic value; their long-term use warrants caution due to potential impacts on microbiota. Future research should aim to identify EO-based interventions that can synergistically restore GBA homeostasis and mitigate neurodegenerative and gastrointestinal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Biotechnology (FaBiT), Food Chemistry and Nutraceutical Lab, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
- Health Sciences and Technologies-Interdepartmental Center for Industrial Research (CIRI-SDV), Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, 40138 Bologna, Italy.
- Valsambro S.r.l., 40121 Bologna, Italy.
ORCID-Profile: Luca Camarda, Ivan Corazza, Roberta Budriesi
Zitieren
APA
Camarda, L., Mattioli, L. B., Corazza, I., Marzetti, C., & Budriesi, R. (2025). Targeting the Gut–Brain Axis with Plant-Derived Essential Oils: Phytocannabinoids and Beyond. Nutrients, 17(9), 1578. https://doi.org/10.3390/nu17091578
Vancouver
Camarda L, Mattioli LB, Corazza I, Marzetti C, Budriesi R. Targeting the Gut–Brain Axis with Plant-Derived Essential Oils: Phytocannabinoids and Beyond. Nutrients. 2025;17(9):1578. doi:10.3390/nu17091578
BibTeX
@article{Camarda2025,
author = {Camarda, Luca and Mattioli, Laura Beatrice and Corazza, Ivan and Marzetti, Carla and Budriesi, Roberta},
title = {Targeting the Gut–Brain Axis with Plant-Derived Essential Oils: Phytocannabinoids and Beyond},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {9},
pages = {1578},
doi = {10.3390/nu17091578}
}
EUVIMED